欧洲复苏委员会复苏指南：2018 年更新-心律失常药物治疗心脏骤停。
European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.
机构信息
European Resuscitation Council, Emile Vanderveldelaan 35, BE-2845, Niel, Belgium.
European Resuscitation Council, Emile Vanderveldelaan 35, BE-2845, Niel, Belgium.
出版信息
Resuscitation. 2019 Jan;134:99-103. doi: 10.1016/j.resuscitation.2018.11.018. Epub 2018 Nov 26.
This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.
这份欧洲复苏委员会（ERC）2018 年复苏指南更新版专注于在成人、儿童和婴儿伴休克的难治性室颤/无脉性室性心动过速的心脏骤停期间，抗心律失常药物在高级生命支持中的作用。这一更新版是在国际复苏联合会（ILCOR）2018 年心肺复苏和紧急心血管护理科学与治疗建议国际共识（CoSTR）发布之后发布的。ILCOR CoSTR 表明胺碘酮和利多卡因的任何有益效果都相似。这份 ERC 更新版并没有对在难治性休克性心脏骤停的高级生命支持中使用抗心律失常药物的建议做出任何重大改变。
Zotero 插件